Literature DB >> 8982445

Effects of guizhi-fuling-wan on male infertility with varicocele.

H Ishikawa1, M Ohashi, K Hayakawa, S Kaneko, M Hata.   

Abstract

Thirty-seven infertile patients with varicocele were treated with Guizhi-Fuling-Wan (7.5 g/day) for at least 3 months. Before and after the administration, semen qualities such as sperm concentration and motility were examined, and the varicocele was graded. A varicocele disappearance rate of 80% was obtained with 40 out of 50 varicocele, and improvement of sperm concentration and motility were found in 71.4% and 62.1% of patients, respectively. From these results, Guizhi-Fuling-Wan is considered to be effective for circulation disorders in varicocele as well as semen quality.

Entities:  

Mesh：

Year:  1996        PMID： 8982445     DOI： 10.1142/S0192415X96000396

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN： 0192-415X            Impact factor:   4.667


  3 in total

1.  The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.

Authors:  Chi-Chen Lu; Mei-Yi Lin; Syue-Yi Chen; Cheng-Huang Shen; Lih-Geeng Chen; Hsiao-Yen Hsieh; Michael W Y Chan; Cheng-Da Hsu
Journal:  BMC Complement Altern Med       Date:  2013-02-23       Impact factor: 3.659

2.  A Proteomic Approach for the Diagnosis of 'Oketsu' (blood stasis), a Pathophysiologic Concept of Japanese Traditional (Kampo) Medicine.

Authors:  Chinami Matsumoto; Tetsuko Kojima; Kazuo Ogawa; Satoshi Kamegai; Takuya Oyama; Yukari Shibagaki; Tetsuo Kawasaki; Hiroshi Fujinaga; Kozo Takahashi; Hiroaki Hikiami; Hirozo Goto; Chizuru Kiga; Keiichi Koizumi; Hiroaki Sakurai; Hiroshi Muramoto; Yutaka Shimada; Masahiro Yamamoto; Katsutoshi Terasawa; Shuichi Takeda; Ikuo Saiki
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-15       Impact factor: 2.629

Review 3.  An update on the role of medical treatment including antioxidant therapy in varicocele.

Authors:  Harshit Garg; Rajeev Kumar
Journal:  Asian J Androl       Date:  2016 Mar-Apr       Impact factor: 3.285
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.